These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36597379)

  • 41. Nasopharyngeal carcinoma with central nervous system metastases: Two case reports and a review of the literature.
    Shen C; Ying H; Lu X; Hu C
    Medicine (Baltimore); 2017 Dec; 96(49):e9175. PubMed ID: 29245363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Necessity of concurrent chemotherapy in N2-3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity-modulated radiotherapy.
    Chang H; Peng L; Tao YL; Chen C; Xiao WW; Hu YH; Gao YH
    Cancer Med; 2019 Jun; 8(6):2823-2831. PubMed ID: 31006996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Five-year disease-free survival of Epstein-Barr virus-associated locoregionally advanced undifferentiated nasopharyngeal carcinoma patients treated with chemo-radiotherapy: a case report.
    Wang N; Wang H; Jiang H; Bi Y; Zhao Y; He X; Cao F; Yuan Y
    Ann Palliat Med; 2022 Mar; 11(3):1147-1152. PubMed ID: 35365045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasopharyngeal carcinoma with leptomeningeal metastases has been treated with comprehensive treatment for long-term survival: A case report and literature review.
    Yang Y; Jiang J; Liu Y; Feng S; Bu H
    Medicine (Baltimore); 2024 Jun; 103(23):e37853. PubMed ID: 38847717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T
    Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective study.
    Li SW; Wang H; Liu ML; Zhang HB; Xiang YQ; Lv X; Xia WX; Zeng MS; Mai HQ; Hong MH; Guo X
    Med Oncol; 2013 Mar; 30(1):322. PubMed ID: 23254962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of intensity-modulated radiation therapy alone vs. intensity-modulated radiation therapy combined with chemotherapy in elderly nasopharyngeal carcinoma patients (aged >65 years).
    Mi JL; Meng YL; Wu HL; Cao YL; Zhang B; Pan YF; Zhou YY; Fan JF; Liao SF; Qin XL; Yao DC; Jiang W
    Strahlenther Onkol; 2020 Mar; 196(3):270-279. PubMed ID: 31748837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
    Yang Q; Cao SM; Guo L; Hua YJ; Huang PY; Zhang XL; Lin M; You R; Zou X; Liu YP; Xie YL; Wang ZQ; Mai HQ; Chen QY; Tang LQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Li JB; Ling L; Guo X; Hong MH; Chen MY
    Eur J Cancer; 2019 Sep; 119():87-96. PubMed ID: 31425966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis.
    Nong S; Pan X; Chen K; Li Y; Zhu X
    Med Sci Monit; 2020 Jun; 26():e922244. PubMed ID: 32541642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.
    Hong RL; Hsiao CF; Ting LL; Ko JY; Wang CW; Chang JTC; Lou PJ; Wang HM; Tsai MH; Lai SC; Liu TW
    Ann Oncol; 2018 Sep; 29(9):1972-1979. PubMed ID: 30016391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salvage Endoscopic Skull Base Surgery: Another Treatment Option After Immunotherapy for Recurrent Nasopharyngeal Carcinoma.
    Peng Z; Wang Y; Fang Y; Wang Y; Yuan X; Shuai M; Xie S; Fan R; Zhang H; Xie Z; Jiang W
    Front Immunol; 2022; 13():899932. PubMed ID: 35686123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up.
    Wang L; Wu Z; Cheng W; Xie D; Lin F; Xia L; Su Y
    Radiat Oncol; 2021 Nov; 16(1):215. PubMed ID: 34742304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
    Liu GY; Lv X; Wu YS; Mao MJ; Ye YF; Yu YH; Liang H; Yang J; Ke LR; Qiu WZ; Huang XJ; Li WZ; Guo X; Xiang YQ; Xia WX
    Cancer Commun (Lond); 2018 May; 38(1):21. PubMed ID: 29764487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current management of stage IV nasopharyngeal carcinoma without distant metastasis.
    Ng WT; Corry J; Langendijk JA; Lee AWM; Mäkitie A; Mendenhall WM; Rinaldo A; Rodrigo JP; Saba NF; Smee R; Strojan P; Suárez C; Vermorken JB; Ferlito A
    Cancer Treat Rev; 2020 Apr; 85():101995. PubMed ID: 32113080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemoradiotherapy combined with NK cell transfer in a patient with recurrent and metastatic nasopharyngeal carcinoma inducing long-term tumor control: A case report.
    Jin YY; Yang WZ; Zou S; Sun ZY; Wu CT; Yang ZY
    Medicine (Baltimore); 2020 Oct; 99(43):e22785. PubMed ID: 33120792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
    Fang FM; Huang TL; Lin YH; Chien CY; Chuang HC; Luo SD; Lin HC; Lin YT; Li SH; Liao KC; Tsai WL
    Head Neck; 2019 May; 41(5):1282-1289. PubMed ID: 30548091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis.
    Kim JS; Keam B; Heo DS; Han DH; Rhee CS; Kim JH; Jung KC; Wu HG
    Cancer Res Treat; 2019 Oct; 51(4):1313-1323. PubMed ID: 30699498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical metastasis of nasopharyngeal cancer: noncontiguous spread to the ipsilateral ear.
    Sandler ML; Sims JR; Xing MH; Khorsand AS; Brandwein-Weber M; Lee NY; Urken ML
    Clin Imaging; 2021 Apr; 72():70-74. PubMed ID: 33217673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
    Zong JF; Liang QD; Lu QJ; Liu YH; Xu HC; Chen BJ; Guo QJ; Xu Y; Hu CR; Pan JJ; Lin SJ
    BMC Cancer; 2021 Nov; 21(1):1274. PubMed ID: 34823489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
    BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.